| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Net income (loss) | -1,053 | -10,701 | NaN |
| Net income attributable to noncontrolling interest | 339 | NaN | NaN |
| Depreciation and amortization | 12,553 | 11,873 | 33,609 |
| Deferred income taxes | NaN | 79 | 6 |
| Net loss | NaN | NaN | -7,151 |
| Right-of-use operating lease amortization and interest | 1,869 | 1,681 | 4,753 |
| Payments of operating leases, including interest | 1,823 | 1,612 | 4,526 |
| Stock-based compensation | 982 | 1,410 | 2,625 |
| Gain on disposals of property and equipment | 70 | 329 | 896 |
| Amortization of financing costs and accretion of purchase price payable | 123 | 162 | 401 |
| Change in fair value of derivative liability - interest rate swaps | 24 | 10 | 442 |
| Loss (gain) on foreign currency transactions | 73 | -136 | -231 |
| Share of loss in equity method investment | -46 | -79 | -245 |
| Net decrease (increase) in accounts receivable | 223 | -468 | -2,107 |
| Net decrease (increase) in inventory | 1,282 | -726 | 3,143 |
| Net decrease (increase) in prepaid and other current assets | 633 | -1,725 | -468 |
| Net decrease in deferred revenue | -162 | 46 | -67 |
| Net decrease in accounts payables and accrued liabilities | -1,628 | -3,106 | -306 |
| Net cash flow provided by operating activities | 8,941 | 9,778 | 27,914 |
| Purchases of property and equipment | 2,074 | 1,824 | 10,530 |
| Cash proceeds from sale of property and equipment | 126 | 314 | 919 |
| Cash paid for acquisitions, net of cash acquired | NaN | 21,824 | NaN |
| Other, net | NaN | 79 | -158 |
| Net cash flow used in investing activities | -1,948 | -23,334 | -9,611 |
| Gross borrowings on the revolving credit facility | NaN | 6,250 | 12,000 |
| Repayments of equipment loans | 6,159 | 5,959 | 18,513 |
| Repayments of finance leases | 322 | 321 | 1,115 |
| Borrowings on delayed-draw term loan | NaN | 17,400 | NaN |
| Repayments of senior credit facility | 1,080 | 1,080 | 2,588 |
| Gross repayments on the revolving credit facility | 2,507 | 1,000 | 12,623 |
| Repurchase of shares, net of issuance costs | NaN | 130 | NaN |
| Exercise of stock options | 629 | NaN | NaN |
| Net cash flow used in financing activities | -9,439 | 15,239 | -22,997 |
| Net increase (decrease) in cash | NaN | -3,011 | NaN |
| Effect of exchange rate changes on cash held in foreign currencies | 73 | -17 | -230 |
| Net decrease in cash | 2,551 | NaN | -4,924 |
| Cash and cash equivalents at beginning of period | 12,916 | 16,174 | NaN |
| Cash and cash equivalents at end of period | 10,543 | 12,916 | NaN |
Quipt Home Medical Corp. (QIPT)
Quipt Home Medical Corp. (QIPT)